Saturday - January 17, 2026
SEC Charges Biopharmaceutical Company Consultant With Insider Trading
January 16, 2026
WASHINGTON, Jan. 16 -- The Securities and Exchange Commission issued the following litigation release (No. 26-civ-10140; D. Mass. filed Jan. 14, 2026):

* * *

Securities and Exchange Commission v. Hong (John) Wang and Precision Clinical Consulting, LLC, No. 26-civ-10140 (D. Mass. filed Jan. 14, 2026)

On January 14, 2026, the Securities and Exchange Commission charged New Jersey resident Hong (John) Wang and his company, Precision Clinical Consulting LLC, wit . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products